These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 18264906)
1. [Gadolinium: a true problem for the nephrologists?]. Balducci A; Tamburrini O G Ital Nefrol; 2008; 25(1):3-4. PubMed ID: 18264906 [No Abstract] [Full Text] [Related]
3. Gadolinium and kidney disease: are your patients at risk? Hollister D Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687 [No Abstract] [Full Text] [Related]
4. How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease? Perazella MA Clin J Am Soc Nephrol; 2008 May; 3(3):649-51. PubMed ID: 18385396 [No Abstract] [Full Text] [Related]
5. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness. Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720 [TBL] [Abstract][Full Text] [Related]
6. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)? Thomsen HS; Morcos SK; Dawson P Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301 [No Abstract] [Full Text] [Related]
7. What nephrologists need to know about gadolinium. Penfield JG; Reilly RF Nat Clin Pract Nephrol; 2007 Dec; 3(12):654-68. PubMed ID: 18033225 [TBL] [Abstract][Full Text] [Related]
8. Extracellular Gd-CA: differences in prevalence of NSF. Thomsen HS; Marckmann P Eur J Radiol; 2008 May; 66(2):180-3. PubMed ID: 18342468 [TBL] [Abstract][Full Text] [Related]
9. [How safe are gadolinium-based contrast media? Nominal ranges for usage?]. Jopp HA Radiologe; 2009 Apr; 49(4):344-7. PubMed ID: 19387605 [No Abstract] [Full Text] [Related]
10. Nephrogenic systemic fibrosis--implications for nephrologists. Saab G; Abu-Alfa A Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470 [TBL] [Abstract][Full Text] [Related]
14. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger? Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754 [TBL] [Abstract][Full Text] [Related]
15. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure]. Michelet PR; Chopard CS; Martin PY; Vallée JP Rev Med Suisse; 2008 Mar; 4(147):576-8, 580. PubMed ID: 18402015 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. High WA; Ayers RA; Cowper SE J Am Acad Dermatol; 2007 Apr; 56(4):710-2. PubMed ID: 17289213 [No Abstract] [Full Text] [Related]
17. Renal failure and gadolinium. The number of documented cases is rising. Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311 [No Abstract] [Full Text] [Related]
18. Nephrogenic system fibrosis: a radiologist's practical perspective. Martin DR Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672 [TBL] [Abstract][Full Text] [Related]